Vertex Pharmaceuticals Incorporated · NASDAQ:VRTX

Capital Research Global Investors reported a 8.30% stake in Vertex Pharmaceuticals Incorporated (Schedule 13G/A)

Event Mar 31, 2026 · Filed May 14, 2026

Capital Research Global Investors reported a 8.30% stake in Vertex Pharmaceuticals Incorporated, 21,139,169 shares, as a passive investor on Mar 31, 2026. Filed May 14, 2026 (Schedule 13G/A).

Stake
8.30%
Shares
21,139,169
Intent
Passive
What changed
Stake changed

The filing in full

HolderStakeShares
Capital Research Global Investors8.30%21,139,169

Source

View original at SEC

Related